Valentine's Day shopping for your wife should be easy. You've known her forever. You hear her talk about her interests on a daily basis. But finding something to showcase how much ...

Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

However, options exist to stretch the relief period beyond that mark based on the investor or insurer. Capitalize on high interest rates: Best current CD rates Borrowers often turn to banks for ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Whether it's for sore muscles, poor sleep, or too much sitting, a good roller makes all the difference. One editor-approved ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...